ATHENS, OH, Resilient Medical Corp (Resilient) received its initial investment funding from the TechGrowth Ohio (TGO) Fund.
Resilient Medical Corp (Resilient) received its initial investment funding from the TechGrowth Ohio (TGO) Fund.
Resilient's Bravo device has the potential to make an enormous impact in breast cancer treatment and lumpectomy procedures, with potential applications in the broader reconstructive surgery space.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
